Oxurion to Participate in Needham Virtual Healthcare Conference

March 28, 2022

Leuven, BELGIUM, Boston, MA, US - MARCH 28, 2022 – 8.00 AM CET   Oxurion NV (Euronext Brussels: OXUR) (the "Company" or "Oxurion"), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, announces today that Tom Graney, Chief Executive Officer, will present at the 21st Annual Needham Virtual Healthcare Conference on Monday, April 11, 2022 at 9:30 AM ET.

A live webcast and 90-day archive will be available in the “Investors” section of the Company’s website.